TNF and rheumatoid arthritis: Currently, the mainstay of clinical treatment for RA includes Janus kinase (JAK) inhibitors, biological agents (e.g., TNF-α inhibitors), and traditional disease-modifying antirheumatic drugs (DMARDs).